MariMed Files Definitive Proxy for Special Meeting to Approve Reverse Stock Split

MariMed Inc. filed a proxy statement for a special meeting seeking approval to implement a reverse stock split at the Board's discretion, aiming to achieve the minimum share price requirements necessary for a potential listing on a U.S. national securities exchange.